ArticleJournal of the American Heart Association2025

Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.

Daniele Massera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.